# Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Study · id `cardio:ct-nct05102019` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05102019](<https://clinicaltrials.gov/study/NCT05102019>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05102019

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.

## Technical summary

Registry record NCT05102019. Randomized; double masking; primary purpose treatment. Start 2022-01-04 (actual); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 380 participants (planned count; ClinicalTrials.gov record NCT05102019, source copy `cardio:ctgov-nct05102019-2026-09-30`, retrieved 2026-11-18)
- Started: 2022-01-04 (actual) (ClinicalTrials.gov record NCT05102019, source copy `cardio:ctgov-nct05102019-2026-09-30`, retrieved 2026-11-18)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05102019, source copy `cardio:ctgov-nct05102019-2026-09-30`, retrieved 2026-11-18)
- Completion: 2032-01 (anticipated) (ClinicalTrials.gov record NCT05102019, source copy `cardio:ctgov-nct05102019-2026-09-30`, retrieved 2026-11-18)
- Countries: United States; Canada; United Kingdom (ClinicalTrials.gov record NCT05102019, source copy `cardio:ctgov-nct05102019-2026-09-30`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05102019-2026-09-30`, retrieved 2026-11-18)

## The registry's words

- Brief title: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
- Acronym: COSIRA-II
- Condition: Refractory Angina
- Intervention (Device): Arm 1: treatment with Shockwave Reducer
- Intervention (Other): Arm 2 (control): Implantation procedure with no device implanted
- Intervention (Device): Arm 3 (unblinded, non-randomized): Single arm registry
- Lead sponsor: Shockwave Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry lists this organization as the lead sponsor: Shockwave Medical, Inc. (`cardio:org-shockwave-medical-inc`)

## Provenance

Content hash: b9cf13c650a815a4ef6f985fc55c7578b610067d940b8b0b4f0880be6bda61b1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
